Log in to save to my catalogue

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal...

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6271363

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs

About this item

Full title

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

Journal of veterinary internal medicine, 2018-11, Vol.32 (6), p.2045-2053

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Gastrointestinal stromal tumors (GISTs) are uncommon intestinal neoplasms in the dog. Literature regarding adjunctive therapy for GISTs in dogs is sparse. High‐risk GISTs in humans respond to tyrosine kinase inhibition in the adjuvant setting.
Objectives
To review cases of toceranib phosphate use in dogs with GISTs and provide i...

Alternative Titles

Full title

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6271363

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6271363

Other Identifiers

ISSN

0891-6640

E-ISSN

1939-1676

DOI

10.1111/jvim.15335

How to access this item